CODY MCBRIDE: Open Payments
NPI 1689038812 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 31 payments from 12 companies in 2025. Trend: 2023 $2,668 · 2024 $446 · 2025 $775
Food & beverage: $540Education: $235
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $294 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Stemline Therapeutics Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Genentech USA, Inc. | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Elucent Medical | 2 | $32 |
| Eisai Inc. | 1 | $31 |
| TerSera Therapeutics LLC | 1 | $23 |
Products named: KISQALI, Enhertu, Orserdu, VERZENIO, KEYTRUDA, Lenvima, Phesgo, Zoladex.
Industry payments across OK — which companies pay providers there.
